Abstract Neuroinflammation plays a critical role in the progression of many neurodegenerative, neuropsychiatric and viral diseases. In neuroinflammation, activated microglia and astrocytes release cytokines and chemokines as well as nitric oxide, which in turn activate many signal transduction pathways. The cytokines, interleukin-1 beta and tumor necrosis factor alpha, regulate transcription of a number of genes within the brain, which can lead to the formation of pro-inflammatory products of the arachidonic acid cascade. Formation of pro-inflammatory agents and associated cytotoxic products during neuroinflammation can be detrimental to neurons by altering synaptic proteins. Neuroinflammation as well as excitotoxic insults reduce synaptic markers such as synaptophysin and drebrin. Neurodegenerative, neuropsychiatric illnesses and viral infections are accompanied by loss of both pre-and postsynaptic proteins. These synaptic changes may contribute to the progressive cognitive decline and behavioral changes associated with these illnesses.
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Neuroinflammation plays a crucial role in the development and progression of neurodegenerative, neuropsychiatric and viral illnesses, including Alzheimer's disease (AD), Parkinson's disease, Huntington's disease, bipolar disorder (BD), schizophrenia (SZ), depression and human immunodeficiency virus (HIV)-associated dementia (HAD) [1] [2] [3] [4] [5] [6] [7] [8] . Neuroinflammation refers to the rapid reaction of the central nervous system (CNS) through activation of the resident immune cells to infections, trauma, toxins, and stroke, among other stimuli [9] . Neuroinflammation is a complex combination of acute and chronic responses of cells within the CNS, including neurons, microglia, astrocytes and infiltrating leukocytes. Infection, trauma, toxins and other insults are capable of producing an immediate short lived induction of the innate immune response within the CNS [10, 11] . This triggers activation of resident microglia and release of pro-inflammatory mediators such as cytokines, chemokines such as prostaglandin E 2 (PGE 2 ), and nitric oxide [12] . Astrocytes are also activated in response to various insults, from subtle changes in their microenvironment to massive tissue damage, and this process is known as astrogliosis [13] . Reactive astrocytes release a wide variety of mediators, including pro-and anti-inflammatory cytokines, neurotrophic factors, chemokines, complement factors and reactive oxygen species (ROS), which mediate neuroprotective and/ or neurotoxic effects [13] [14] [15] . Astrocyte-derived cytokines such as interleukin (IL)-1b and tumor necrosis factor-a (TNFa) are considered to promote neurotoxicity whereas others including IL-6 and transforming growth factor-b (TGFb), are neuroprotective [14] [15] [16] . The acute insult and neuroinflammation response typically are short-lived and unlikely to be harmful to neuronal survival [17, 18] . The acute response is resolved in part by a negative feedback pathway mediated by PGE 2 that results in reduced levels of IL-1b and TNFa [19] . Acute neuroinflammation is believed to be beneficial in the CNS, since it tends to minimize further injury and contributes to repair of damaged tissue. On the other hand, chronic neuroinflammation produces long-lasting and self-perpetuating neuroinflammatory mediators that remain after the initial neuroinflammatory insult has passed. It is thought that chronic inflammation is detrimental to neurons in many disorders [18, 20] . IL-1b and TNFa released from microglia and astrocytes bind their respective receptors and upregulate transcription of a number genes including genes for the arachidonic acid (AA) cascade such as cytosolic phospholipase A 2 (cPLA 2 ), secretory PLA 2 (sPLA 2 ), and cyclooxygenase-2 (COX-2) via the nuclear kappa B pathway [19, [21] [22] [23] . AA is a nutritionally essential polyunsaturated fatty acid predominately found in the stereospecifically numbered-2 (sn-2) position of membrane phospholipids. AA can be hydrolyzed from membrane phospholipids by calcium-dependent AA-selective cPLA 2 IVa or sPLA 2 IIa [24] . The released AA can be converted into pro-inflammatory lipid mediators, such as prostaglandin (PGH 2 ), leukotrienes, and related compounds by the action of COX, lipoxygenase (LOX) and thromboxane synthase (TXS) enzymes. PGH 2 is converted to PGE 2 by membrane prostaglandin E synthase (mPGES) or cytosolic PGES (cPGES), or by TXS to thromboxane A 2 (TXA 2 ) (Fig. 1) .
Synaptic Proteins
Several pre-and post-synaptic proteins have been characterized including synaptophysin and drebrin. Synaptophysin is a 38-kd glycoprotein localized in presynaptic vesicle membranes. Based on amino acid sequences the predicted secondary structure of mammalian synaptophysin consists of four transmembrane a-helices, two intravesicular loops, and cytoplasmic N-and C-termini. The C-terminus contains a Ca 2? binding motif and ten pentapeptide repeats, nine of which contain tyrosine residues which are phosphorylated by Src in vitro [25] . Electron microscopy examination of the morphology of retinal photoreceptors in the synaptophysin/synaptogyrin knockout mice revealed a defect in synaptic vesicle endocytosis [26] . Synaptophysin is also required for synaptobrevin retrieval during endocytosis [27] . Membrane trafficking functions of synaptophysin include the docking and fusion of neurotransmittercontaining synaptic vesicles as well as endocytosis [25] . Synaptophysin knockout (KO) mice exhibit learning deficits in behavioral paradigms [28] . Drebrin, one of the most abundant neuron-specific F-actin-binding proteins, is found exclusively in dendrites and is particularly concentrated in dendritic spines receiving excitatory inputs [29] . Drebrin expression is maximal during embryogenesis and decreases thereafter [30] . The over-expression of drebrin provokes elongation of dendritic spines in mature neurons [31] and changes dendritic filopodia into aberrantly enlarged megapodia in immature neurons [32] . Conversely, suppression of drebrin expression reduces spine density and results in the formation of thin immature spines [33] . These findings show that the drebrin-actin complex plays a crucial role in the regulation of dendritic spine morphology. The synaptic proteins affect the presynaptic storage of neurotransmitters as well as the post-synaptic density, size and stability of dendritic spines [34] . Dendritic spines are the primary site for post-synaptic excitatory neurotransmitter mediated signaling. Drebrin is involved in clustering of the postsynaptic density (PSD) scaffold protein, PSD-95 in dendritic spines [35] , as well as in the activity-dependent synaptic targeting of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors [36] . Long-term potentiation (LTP) in the hippocampus is involved in enhanced drebrin content within dendritic spines [37] . All these findings indicate that drebrin expressed in spines can modulate synaptic activity (Table 1) .
Altered Synaptic Proteins in Neurodegenerative Disease, Neuropsychiatric Illnesses and Aging
Several studies have indicated that chronic neuroinflammation coexists with neurodegeneration associated with synaptic proteins loss. Hatanpää et al. reported decreased drebrin in postmortem cerebral cortex from AD as well as from healthy older subjects [8, 38] . Studies also report that drebrin is decreased in postmortem hippocampal [39] and temporal cortical regions obtained from mildly to severely cognitively impaired patients [40] . More recently, Table 1) .
Various risk factors could contribute to the reduction in synaptophysin and drebrin in brain. These include neuroinflammatory agents, excitotoxicity, other toxic metabolites such as nitric oxide, AA and its metabolites.
Neuroinflammation
During neuroinflammation, proinflammatory cytokines such as IL-1b, TNFa, IL-6 and chemokines including interferon gamma, macrophage inflammatory protein and inducible protein (IP)-10 are released by activated microglia and astrocytes in response to an insult. IL-1b and TNFa regulate transcription of many genes, including genes for AA cascade enzymes in various cell types, via nuclear factor kappa B (NF-jB) or activator protein (AP)-2 [66] [67] [68] [69] [70] . The decreased drebrin in AD might be due to upregulated neuroinflammatory and AA cascade markers, since excess TNFa, IL-1b and AA have been shown to damage neurons by activating pro-apoptotic factors and caspase-3 [71] [72] [73] . These findings support the idea that neuroinflammation is involved in reducing the synaptic proteins. Animal models such as HIV-1 transgenic rats, n-3 PUFA deprived rats and rats exposed to a high dose of LPS by intracerebral ventricular infusion all exhibit increased brain cytokines such as IL-1b, TNFa, and markers of AA metabolism [4, 74] ; (Kellom et al. unpublished data). However, low-dose infusion of LPS (1.0 lg/ml) for 6 days increased TNFa protein without changes in cPLA 2 mRNA or drebrin protein in rat brain. This suggests that TNFa alone cannot decrease drebrin levels in brain. Together, these findings suggest that neuroinflammation associated with increased AA signaling can downregulate drebrin levels in rat brain. Chronic LPS infusion (1 lg/ml) into the fourth ventricle for 28 days in rats increased neuroinflammatory markers and impaired behavior [75] . Chronic NMDA administration at non-convulsive doses to rats upregulated brain AA turnover, cPLA 2 expression and upregulated protein and mRNA levels of neuroinflammatory markers such as IL-1b, TNFa, glial fibrillary acidic protein (GFAP) and iNOS [76] [77] [78] . These studies imply that excitotoxicity and neuroinflammation pathways crosstalk with each other and involve AA signaling. Further, chronic NMDA administration to rats upregulated the proapoptotic factors Bad and Bax, which cause neuronal loss [79] . The combination of neuroinflammation and increased AA signaling could promote synaptic loss (Fig. 2) .
In the brain, AA and its metabolites influence signal transduction, gene transcription, neuronal activity, apoptosis, and other processes [80] [81] [82] . Dietary n-3 PUFA deprivation in rats upregulates brain AA signaling and increases activity and transcription of cPLA 2 and sPLA 2 [83] . These findings suggest that either neuroinflammation or an upregulated AA cascade could reduce levels of synaptic proteins although the mechanism for this is not clear. Drebrin is regulated by the transcriptional factor NXF and its transcription can be modulated by docosahexaenoic acid (DHA) via phosphatidylinositol kinase (PIK) [84, 85] . Perhaps AA acts on this PIK and the transcription factor of drebrin to reduce drebrin transcription. A cPLA 2 inhibitor protected against prion and amyloid beta 1-42 induced synaptic loss in cultured rat cortical and hippocampal neurons [86] which is consistent with the idea that elevated AA is detrimental to neurons. Further detailed molecular studies are needed to understand the effects of AA and its proinflammatory metabolites on transcription factors of key synaptic proteins such as drebrin and synaptophysin. AA and DHA are incorporated into the sn-2 position of phospholipids in the plasma membrane (PM) of neurons. The benefits of DHA may be due in part to its highly unsaturated structure and the resulting increased fluidity of the PM. Released DHA is metabolized into anti-inflammatory derivatives, resolvins and neuroprotectins by LOX enzymes [87] . A deficiency of DHA could lead to increased incorporation of AA into brain phospholipids. AA is released from the PM by cPLA 2 and is metabolized into the pro-inflammatory compounds prostaglandins, leucotrienes and hydroxyeicosatetraenoic acid.
Cross-talk Between Neuroinflammation and Excitotoxicity
Neuroinflammatory and AA cascade markers are elevated by excitotoxicity. Activated microglia release nitric oxide, which blocks reuptake of glutamate at the presynaptic site. The resulting increased glutamate at the synaptic cleft prolongs activation of NMDA receptors. Activation of NMDA receptors increases cPLA 2 activity and protein and mRNA levels in an AP-2 dependent manner [77] . In addition, chronic NMDA administration to rats upregulates levels of proinflammatory IL-1b, TNFa, GFAP and iNOS in rat brain [76] . Together, these findings suggest that there is cross-talk between neuroinflammation and excitotoxicity that involves release of AA. Upregulation of neuroinflammatory and of AA cascade markers in chronic NMDAadministered rats was shown to cause neuronal loss [79] . This suggests that both neuroinflammation and an elevated AA cascade are detrimental to neuronal survival. Under these conditions, synaptic markers (synaptophysin and drebrin) also are decreased (Fig. 2) .
Nitric Oxide
Nitric oxide (NO) released by NO synthase (nNOS) may induce synaptic changes. Upregulation of neuronal (nNOS) occurs in neurodegenerative diseases such as amyotrophic lateral sclerosis [88] , PD [89] , and AD [90] . iNOS also is upregulated in glial cells in these diseases as well as in multiple sclerosis and in HAD [91, 92] . In an animal study, increased nNOS expression caused synapse loss in motoneurons of both neonatants and adult male Wistar rats [93] .
Mechanism
The exact mechanisms by which synaptic proteins are affected by neuroinflammation are not clear. Several studies have shown inhibition of p38 mitogen activated kinase activity prevented the cytokine induced loss of synaptophysin in rat primary cortical neuronal cultures and in an animal model of AD [94, 95] . Drebrin is regulated by the transcriptional factor NXF and is modulated by DHA via PI kinase [84, 85] . The loss of drebrin induced by LPS is implicated by increased activity of p38 MAP kinase in mouse hippocamapal cultures [96] . Neuroinflammatory cytokines such as IL-1b and TNFa may regulate drebrin and synaptophysin via various kinases. AA release by cPLA 2 is stimulated by cytokines, which might have a direct or an indirect role in regulating synaptic proteins in brain. Further studies are warranted to understand the mechanisms by which synaptic proteins are regulated during neuroinflammation.
Drugs
The antidepressant fluoxetine, upon chronic administration to rats, increased hippocampal drebrin protein [97] , but olanzapine and haloperidol did not change the proteins that regulate drebrin level in monkeys [98] .
Conclusions
Increased neuroinflammation can alter the integrity of synapses by altering essential post and presynaptic proteins including drebrin and synaptophysin. These changes may contribute to cognitive impairment in neurodegenerative and neuropsychiatric illnesses. 
